Klogene Therapeutics, Inc. awarded a $1.49 Million grant for Alzheimers disease drug development
May 16, 2016
$1.49 Million from NIH for Prof’s Alzheimer’s Start-Up
August 26, 2016
BU, Harvard researchers bootstrap a new approach to Alzheimer’s R&D
January 22, 2018
Klogene scientists are first to use CRISPR in Klotho activation
Comments are closed.